Researchers Discover Biomarkers for Early Diagnosis of Alzheimer’s Disease

FREMONT, CA (July 19, 2004) – Ciphergen Biosystems, Inc. announced that ten studies involving Seldi ProteinChip Technology for various aspects of Alzheimer’s Disease research will be presented at the 9th International Conference on Alzheimer’s Disease in Philadelphia on July 17-22.

These studies have identified biomarkers and biomarker patterns that may lead to improved early detection of Alzheimer’s and suggest new targets for therapeutic intervention. Among these presentations, Prof. Kaj Blennow, M.D., Ph.D. from the University of Gothenburg, Sweden will be presenting data from a recent study done in collaboration with Ciphergen’s Diagnostics Division during his plenary lecture on July 22 on “Biomarker’s in Alzheimer’s Disease.”

Ciphergen’s Biosystems Division develops, manufactures and markets a family of ProteinChip Systems and services for clinical, research, and process proteomics applications, as well as bioseparations media for protein purification and large scale production.